Skip to main content
NCBI home page
British Journal of Pharmacology and Chemotherapy logoLink to British Journal of Pharmacology and Chemotherapy
. 1964 Apr;22(2):267–274. doi: 10.1111/j.1476-5381.1964.tb02032.x

The effect of fasting on the hyperglycaemic responses to catechol amines in rats

W W Fleming, A D Kenny
PMCID: PMC1703983  PMID: 14190462

Abstract

The relative activities of adrenaline, noradrenaline and isoprenaline in producing hyperglycaemia and glycogenolysis in skeletal muscle have been studied in both fed and fasted rats, 1 hr after subcutaneous injection of the catechol amines. The relative hyperglycaemic activities of the three catechol amines depended greatly upon the prandial state of the rats and on the dose range used. In fed rats the relative potencies were in the descending order of potency, adrenaline—noradrenaline—isoprenaline, irrespective of the dose range. Isoprenaline had no hyperglycaemic activity in fed rats even at doses as high as 2 mg/kg. In fasted rats the order of potency depended on the dose. At low doses (0.005 to 0.02 mg/kg) the descending order was isoprenaline—adrenaline—noradrenaline. At higher doses (0.1 to 1 mg/kg) the descending order was adrenaline—isoprenaline—noradrenaline. The relative activities of the three catechol amines in causing glycogenolysis in muscle was independent of the dose range or the prandial state of the rats. Under all conditions the descending order of potency was isoprenaline—adrenaline—noradrenaline. The results are discussed with reference to Ahlquist's (1948) hypothesis of α- and β- receptors and were consistent with the concept that, in the rat, liver glycogenolysis is mediated predominantly by α-receptors and muscle glycogenolysis mainly by β-receptors. In general the hyperglycaemic response in the fed rat is mediated predominantly by α-receptors and in the fasted rat the response is mainly due to the activation of β-receptors. A drug possessing both α- and β-receptor activity elicits an exception to this rule in the fasted rat. Several perturbing problems in the literature, particularly with regard to the hyperglycaemic activity of isoprenaline and to the difficulty in blocking the hyperglycaemic response, can now be explained in the light of these findings.

Full text

PDF
267

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ASHMORE J., PRESTON J. E., LOVE W. C. Effects of dichloroisoproterenol on blood sugar and plasma free fatty acids. Proc Soc Exp Biol Med. 1962 Feb;109:291–294. doi: 10.3181/00379727-109-27182. [DOI] [PubMed] [Google Scholar]
  2. CLAASSEN V., NOACH E. L. Dichloro-isuprel inhibition of sympathomimetic hyperglycaemia. Arch Int Pharmacodyn Ther. 1960 Jul 1;126:332–340. [PubMed] [Google Scholar]
  3. ELLIS S., ANDERSON H. L., Jr, COLLINS M. C. Pharmacologic differentiation between epinephrine- and HGF-hyperglycemias: application in analysis of cobalt-hyperglycemia. Proc Soc Exp Biol Med. 1953 Nov;84(2):383–386. [PubMed] [Google Scholar]
  4. ELLIS S., ANDERSON H. L. The effect of amines on the blood sugar of the rat. J Pharmacol Exp Ther. 1951 Jan;101(1):92–100. [PubMed] [Google Scholar]
  5. ELLIS S., DAVIS A. H., ANDERSON H. L., Jr Effects of epinephrine and related amines on contraction and glycogenolysis of the rats diaphragm. J Pharmacol Exp Ther. 1955 Sep;115(1):120–125. [PubMed] [Google Scholar]
  6. HARVEY S. C., WANG C. Y., NICKERSON M. Blockade of epinephrine-induced hyperglycemia. J Pharmacol Exp Ther. 1952 Mar;104(3):363–376. [PubMed] [Google Scholar]
  7. HYNIE S., WENKE M., MUEHLBACHOVA E. [On the characteristics of the modification of glycide metabolism by adrenomimetics]. Arzneimittelforschung. 1961 Sep;11:858–861. [PubMed] [Google Scholar]
  8. KENNY A. D., MOREY E. R. The hyperglycemic activity of 2, 2'-bipyridine. J Pharmacol Exp Ther. 1962 Mar;135:317–322. [PubMed] [Google Scholar]
  9. LEVY B., AHLQUIST R. P. An analysis of adrenergic blocking activity. J Pharmacol Exp Ther. 1961 Aug;133:202–210. [PubMed] [Google Scholar]
  10. MAYER S., MORAN N. C., FAIN J. The effect of adrenergic blocking agents on some metabolic actions of catecholamines. J Pharmacol Exp Ther. 1961 Oct;134:18–27. [PubMed] [Google Scholar]
  11. MURAD F., CHI Y. M., RALL T. W., SUTHERLAND E. W. Adenyl cyclase. III. The effect of catecholamines and choline esters on the formation of adenosine 3',5'-phosphate by preparations from cardiac muscle and liver. J Biol Chem. 1962 Apr;237:1233–1238. [PubMed] [Google Scholar]
  12. SCHWARTZ N. B. Effect of dibenzyline on the metabolic actions of epinephrine and thyroxine. Am J Physiol. 1962 Sep;203:525–531. doi: 10.1152/ajplegacy.1962.203.3.525. [DOI] [PubMed] [Google Scholar]
  13. TOBE M., KURIHARA N., TAKEUCHI S. Studies on intravenous glucose tolerance curve. 6. Effect of adrenergic blocking agents. Endocrinol Jpn. 1961 Jun;8:77–85. doi: 10.1507/endocrj1954.8.77. [DOI] [PubMed] [Google Scholar]
  14. VAN DER POL M. C. The effect of some sympathicomimetics in relation to the two receptor-theory. III. The effect on the blood sugar content. Acta Physiol Pharmacol Neerl. 1956 Mar;4(4):541–546. [PubMed] [Google Scholar]
  15. VRIJ C., Jr, GHO B. K., DE GROOT C. A., WEBER J. F. The effect of isopropyl-nor-adrenaline and nor-adrenaline on the glycogen-content of skeletal muscle and liver of the rat. Acta Physiol Pharmacol Neerl. 1956 Mar;4(4):547–554. [PubMed] [Google Scholar]
  16. WINTERNITZ W. W., DINTZIS R., LONG C. N. Further studies on the adrenal cortex and carbohydrate metabolism. Endocrinology. 1957 Dec;61(6):724–741. doi: 10.1210/endo-61-6-724. [DOI] [PubMed] [Google Scholar]
  17. van ROY F., SCHULHOF L. W. The effect of sympathomimetics on glycogenolysis of rat liver slices in vitro. Arch Int Pharmacodyn Ther. 1961 Mar 1;130:368–373. [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology and Chemotherapy are provided here courtesy of The British Pharmacological Society

RESOURCES